Breaking News

ICON Partners with Korea National Enterprise

Aims to advance clinical research in South Korea

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON plc, and Korea National Enterprise for Clinical Trials (KoNECT) have partnered to advance clinical trials in South Korea. ICON and KoNECT will collaborate on a series of educational events for local and multinational pharma companies, investigators and industry officials. The program aims to enhance current high standards of clinical research in South Korea and will begin with an oncology trials seminar in Seoul on October 26th.   “South Korea has become a key country for clinical developme...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters